Funding for this research was provided by:
European Molecular Biology Organization
Article History
Received: 15 February 2023
Accepted: 28 July 2023
First Online: 29 November 2023
Competing interests
: M.Y., I.B. and Y.F. are employees and/or shareholders of Augmanity, a privately funded research institute in Rehovot, Israel. The authors declare no competing interests.